---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-123466"
form_type: "8-K"
ticker: "ASMB"
cik: "0001426800"
company_name: "ASSEMBLY BIOSCIENCES, INC."
filed_at: "2024-11-07T23:59:59+00:00"
generated_at: "2026-05-30T03:25:57.859605+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Assembly Biosciences enters ATM equity offering agreement with Jefferies LLC

## Summary
- At-the-market facility permits sale of common stock from time to time; Jefferies acts as agent.
- Jefferies earns up to 3.0% commission on gross proceeds of shares sold under the agreement.
- Sales may occur on Nasdaq, in block trades, or privately; no minimum number of shares required.
- Either party may terminate the Sale Agreement at any time upon written notice.
- Shares to be issued under existing effective shelf registration statement (333-270760).

## SEC filing metadata
- accession: 0000950170-24-123466
- form_type: 8-K
- ticker: ASMB
- cik: 0001426800
- company_name: ASSEMBLY BIOSCIENCES, INC.
- filed_at: 2024-11-07T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1426800/000095017024123466/0000950170-24-123466-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1426800/000095017024123466/asmb-20241107.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-123466
- JSON: https://secwatch.observer/filing/0000950170-24-123466.json
- Plain text: https://secwatch.observer/filing/0000950170-24-123466.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
